Are you Dr. Gressot?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 107 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
17323 Red Oak Dr
Houston, TX 77090Phone+1 281-440-5006Fax+1 281-440-6149
Summary
- Dr. Laurent Gressot, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with HCA Houston Healthcare Northwest, Houston Methodist Willowbrook Hospital, and St. Luke's Health - The Woodlands Hospital.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1989 - 1993
Baylor College of MedicineResidency, Internal Medicine, 1987 - 1989
University of Geneva Faculty of MedicineClass of 1985
Certifications & Licensure
TX State Medical License 1989 - 2021- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) Start of enrollment: 2013 Oct 14
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
- Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsNanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non–Small-cell Lung Cancer (...David R. Spigel, Robert M. Jotte, Santiago Ponce Aix, Laurent Gressot, Daniel Morgensztern
Clinical Lung Cancer. 2021-01-01 - 4 citationsnab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy.Michael Thomas, David R. Spigel, Robert M. Jotte, Michael McCleod, Mark A. Socinski
Lung Cancer. 2017-10-30 - 97 citationsSunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label TrialNicholas J. Robert, Mansoor N. Saleh, Devchand Paul, Daniele Generali, Laurent Gressot
Clinical Breast Cancer. 2011-04-01
Professional Memberships
- Member
